Citation Impact
Citing Papers
Selective blockade of inhibitory Fcγ receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells
2005 StandoutNobel
Cutting Edge: KIR3DS1 , a Gene Implicated in Resistance to Progression to AIDS, Encodes a DAP12-Associated Receptor Expressed on NK Cells That Triggers NK Cell Activation
2007
The activating form of CD94 receptor complex: CD94 covalently associated with the Kp39 protein that represents the product of the NKG2-C gene
1998
Signaling through human killer cell activating receptors triggers tyrosine phosphorylation of an associated protein complex
1998
Killer immunoglobulin-like receptors
2004
Lineage-Specific Changes in Biomarkers in Great Apes and Humans
2015 StandoutNobel
Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
2000 Standout
Expression of human NKRP1A by CD34+ immature thymocytes: NKRP1A‐mediated regulation of proliferation and cytolytic activity
1996
The human natural cytotoxicity receptors (NCR) that induce HLA class I-independent NK cell triggering
2000
Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
2007 Standout
The CD85j+ NK Cell Subset Potently Controls HIV-1 Replication in Autologous Dendritic Cells
2008 StandoutNobel
Natural killer lymphocytes: biology, development, and function
2004
Active immunization against cancer with dendritic cells: The near future
2001 StandoutNobel
Genetic analysis of resistance to viral infection
2007 StandoutNobel
HLA‐G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex
1997
1,4‐Pentenyne as a Five‐Carbon Synthon for Efficient and Selective Syntheses of Natural Products Containing 2,4‐Dimethyl‐1‐penten‐1,5‐ylidene and Related Moieties by Means of Zr‐Catalyzed Carboalumination of Alkynes and Alkenes
2007 StandoutNobel
Reconstituted Killer Cell Inhibitory Receptors for Major Histocompatibility Complex Class I Molecules Control Mast Cell Activation Induced via Immunoreceptor Tyrosine-based Activation Motifs
1997
Human NK cells: from HLA class I‐specific killer Ig‐like receptors to the therapy of acute leukemias
2008
Mesenchymal stem cells in health and disease
2008 Standout
A Novel Family of Inhibitory Receptors for HLA Class I Molecules That Modulate Function of Lymphoid and Myeloid Cells
1999
The Binding Site of NK Receptors on HLA-C Molecules
1997
The CD94 and NKG2‐A C‐type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules
1997
A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity
2008 StandoutNature
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
1998 StandoutNature
The killer cell inhibitory receptor genomic region on human chromosome 19q13.4
1997
Identification and molecular characterization of a natural mutant of the p50.2/KIR2DS2 activating NK receptor that fails to mediate NK cell triggering
2000
Inhibitory Pathways Triggered by ITIM-Containing Receptors
1999
Natural killer cell receptors
1997
Interferon α–Stimulated Natural Killer Cells From Patients With Acute Hepatitis C Virus (HCV) Infection Recognize HCV-Infected and Uninfected Hepatoma Cells via DNAX accessory molecule-1
2012 StandoutNobel
The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor‐alloreactive T cells causing GVHD
2004
Polymorphism and domain variability of human killer cell inhibitory receptors
1997
Natural Killer Cells: From No Receptors to Too Many
1997
Fcγ receptors as regulators of immune responses
2007 Standout
Inhibitory MHC class I receptors on NK cells and T cells
1996
Differential association of phosphatases with hematopoietic co‐receptors bearing immunoreceptor tyrosine‐based inhibition motifs
1997
Expression of killer cell inhibitory receptors on human uterine natural killer cells
1997
Functions of natural killer cells
2008 Standout
Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA‐Cw4 molecules
1997
A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation
1996
PILRα, a Novel Immunoreceptor Tyrosine-based Inhibitory Motif-bearing Protein, Recruits SHP-1 upon Tyrosine Phosphorylation and Is Paired with the Truncated Counterpart PILRβ
2000
Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells
1998 Nature
TREM-1 amplifies inflammation and is a crucial mediator of septic shock
2001 StandoutNature
Regulation of T cell function by NK cell receptors for classical MHC class I molecules
2000
Interleukin‐15‐induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2‐A as the only HLA class I‐specific inhibitory receptor
1997
Human Diversity in Killer Cell Inhibitory Receptor Genes
1997
Killer cell receptors: keeping pace with MHC class I evolution
1997
Positive and negative MHC class I recognition by rat NK cells
1997
Human papillomavirus and cervical cancer
2007 Standout
CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies
1996
Natural killer cell receptors specific for MHC class I molecules
1996
Threonine 80 on HLA‐B27 confers protection against lysis by a group of natural killer clones
1996
Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis
2000
Signal Transduction during Natural Killer Cell Activation: Inside the Mind of a Killer
1997
DAP12-mediated Signal Transduction in Natural Killer Cells
1998
Genomic organization and allelic polymorphism of the human killer cell inhibitory receptor gene KIR 103
1997
HLA class I specific inhibitory receptors
1997
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
2010 Standout
Arousal and inhibition of human NK cells
1997
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
2016 Standout
Neo‐ligands for innate immune receptors and the etiology of sterile inflammatory disease
2007 StandoutNobel
Total synthesis of (+)-scyphostatin featuring an enantioselective and highly efficient route to the side-chain via Zr-catalyzed asymmetric carboalumination of alkenes (ZACA)
2010 StandoutNobel
Paradoxical roles of the immune system during cancer development
2006 Standout
BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1
2003 StandoutNobel
Characterization of an Antigen That Is Recognized on a Melanoma Showing Partial HLA Loss by CTL Expressing an NK Inhibitory Receptor
1997
Human NK cells and their receptors
2002
Identification of a human member of the Ly-49 multigene family
1998
Association of DAP12 with Activating CD94/NKG2C NK Cell Receptors
1998
Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS
2002
Major histocompatibility complex class I‐specific receptors on human natural killer and T lymphocytes
1997
Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells
1999
A Novel Immunoglobulin Superfamily Receptor for Cellular and Viral MHC Class I Molecules
1997
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
2015 Standout
Natural killer cell receptors and MHC class I interactions
1997
Alternatively splicedLy-49D andH transcripts are found in IL-2-activated NK cells
1996
Cutting Edge: Ly-49D and Ly-49H Associate with Mouse DAP12 and Form Activating Receptors
1998
The Direct Binding of a p58 Killer Cell Inhibitory Receptor to Human Histocompatibility Leukocyte Antigen (HLA)-Cw4 Exhibits Peptide Selectivity
1997
Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer
1997 StandoutNobel
NK CELL RECOGNITION
2004 Standout
But Economics Is Not an Experimental Science
2010 StandoutNobel
Molecular Cloning of NKp46: A Novel Member of the Immunoglobulin Superfamily Involved in Triggering of Natural Cytotoxicity
1998
Major Histocompatibility Complex Class I–Recognizing Receptors Are Disease Risk Genes in Rheumatoid Arthritis
2001
The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
2009 Standout
NK Cell Compartments and Their Activation by Dendritic Cells
2004
Human Histocompatibility Leukocyte Antigen (HLA)-G Molecules Inhibit NKAT3 Expressing Natural Killer Cells
1997
Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors
1998
Natural killer cell acceptance of H-2 mismatch bone marrow grafts in transgenic mice expressing HLA-Cw3 specific killer cell inhibitory receptor (CD158b)
1997
NK CELL RECEPTORS
1998 Standout
Nonstochastic Coexpression of Activation Receptors on Murine Natural Killer Cells
2000
PD-L1/B7H-1 Inhibits the Effector Phase of Tumor Rejection by T Cell Receptor (TCR) Transgenic CD8+ T Cells
2004 StandoutNobel
Functionally and Structurally Distinct NK Cell Receptor Repertoires in the Peripheral Blood of Two Human Donors
1997
The lymphoproliferative defect in CTLA-4–deficient mice is ameliorated by an inhibitory NK cell receptor
2002 StandoutNobel
Self and viral peptides can initiate lysis by autologous natural killer cells
1997
Differential natural killer cell–mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes
2007
Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules.
1996
Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis
2001 Standout
Characterization of inhibitory and stimulatory forms of the murine natural killer cell receptor 2B4
1999
Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity
2008
Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells
2002 StandoutNobel
p46, a Novel Natural Killer Cell–specific Surface Molecule That Mediates Cell Activation
1997
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
2018 StandoutNobel
MHC Class I-Independent Recognition of NK-Activating Receptor KIR2DS4
2004
Role of CD47 as a Marker of Self on Red Blood Cells
2000 StandoutScience
Structural Elucidation of Scyphostatin, an Inhibitor of Membrane-Bound Neutral Sphingomyelinase
1997
NK cell receptor gene of the KIR family with two IG domains but highest homology to KIR receptors with three IG domains
1996
The inter-locus recombinant HLA-B*4601 has high selectivity in peptide binding and functions characteristic of HLA-C.
1996
KIR: Diverse, Rapidly Evolving Receptors of Innate and Adaptive Immunity
2002
Costimulation of Multiple NK Cell Activation Receptors by NKG2D
2002
Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2
2001
Genetic Control of Human NK Cell Repertoire
2002
Dendritic cell maturation by innate lymphocytes
2005 StandoutNobel
NKG2A Complexed with CD94 Defines a Novel Inhibitory Natural Killer Cell Receptor
1997
Of Mice and Not Men: Differences between Mouse and Human Immunology
2004 Standout
Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci
2005
PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine
2001 StandoutNobel
Killer Cell Activating Receptors Function as Costimulatory Molecules on CD4+CD28null T Cells Clonally Expanded in Rheumatoid Arthritis
2000
Functional Role for Syk Tyrosine Kinase in Natural Killer Cell–mediated Natural Cytotoxicity
1997
The human natural killer cell immune synapse
1999
Immunobiology of Dendritic Cells
2000 Standout
Decoding the Patterns of Self and Nonself by the Innate Immune System
2002 StandoutScience
TRANSFORMING GROWTH FACTOR-β REGULATION OF IMMUNE RESPONSES
2005 Standout
Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants
2002 StandoutScience
NK cell–mediated killing of target cells triggers robust antigen-specific T cell–mediated and humoral responses
2009 StandoutNobel
Direct binding of a soluble natural killer cell inhibitory receptor to a soluble human leukocyte antigen-Cw4 class I major histocompatibility complex molecule.
1996
Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals
2007 StandoutNobel
Mouse Ly-49D Recognizes H-2Dd and Activates Natural Killer Cell Cytotoxicity
1999
Cutting Edge: Increased NK Cell Activity in HIV-1-Exposed but Uninfected Vietnamese Intravascular Drug Users
2003 StandoutNobel
Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis
1997 Standout
Role of Natural Killer Cell Alloreactivity in HLA-Mismatched Hematopoietic Stem Cell Transplantation
1999
Interaction of Ly-49D+ NK Cells with H-2Dd Target Cells Leads to Dap-12 Phosphorylation and IFN-γ Secretion
2000
Sustained expansion of NKT cells and antigen-specific T cells after injection of α-galactosyl-ceramide loaded mature dendritic cells in cancer patients
2005 StandoutNobel
REGULATION OF IMMUNE RESPONSES THROUGH INHIBITORY RECEPTORS
1999
Preclinical characterization of 1-7F9, a novel human anti–KIR receptor therapeutic antibody that augments natural killer–mediated killing of tumor cells
2009
NKp44, a Novel Triggering Surface Molecule Specifically Expressed by Activated Natural Killer Cells, Is Involved in Non–Major Histocompatibility Complex–restricted Tumor Cell Lysis
1998
NK cells and apoptosis
1999
Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors.
1998
Innate or Adaptive Immunity? The Example of Natural Killer Cells
2011 StandoutScience
Direct Binding and Functional Transfer of NK Cell Inhibitory Receptors Reveal Novel Patterns of HLA-C Allotype Recognition
1998
NATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate Cytokines
1999 Standout
RECEPTORS FOR HLA CLASS-I MOLECULES IN HUMAN NATURAL KILLER CELLS
1996
The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer.
1996
Works of Raffaele Conte being referenced
The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions.
1996
Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones.
1995